However, 68Ga-MY6349 PET/CT exhibited a superior TBR in metastatic lesions compared with that of 68Ga-PSMA-11 PET/CT, leading to the detection of more bone metastases (122 vs. 101; Supplemental Table 4) and comparable lymph node metastases (61 vs. 60). Here, FOLH1 is linked to metastatic malignant neoplasm in the lymph nodes.